Insmed | INSM - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Cytokinetics USD -173.49M 653.08M 2026-06
DBV Technologies USD 160.4M 47.5M 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
Heron Therapeutics USD 6.91M 2.23M 2026-06
Insmed USD 757.49M 52.64M 2026-06
Novartis USD 38.93B 7.2B 2026-03
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06